On August 16, 2023, Jason Ehrlich, M.D., Ph.D., informed Kodiak Sciences Inc. of his resignation as Chief Medical Officer and Chief Development Officer of the Company, effective August 25, 2023. Dr. Ehrlich?s resignation was not the result of a disagreement with the Company on any matter relating to the Company?s operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.61 USD | -5.00% | -4.24% | +18.75% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.75% | 189M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- KOD Stock
- News Kodiak Sciences Inc.
- Jason Ehrlich, M.D., Ph.D., Informs Kodiak Sciences Inc. of His Resignation as Chief Medical Officer and Chief Development Officer, Effective August 25, 2023